Recent lipidomic studies in SLE patients with skin involvement revealed alterations in sphingolipid species and vitamin E metabolites, which correlated with photosensitive phenotypes and anti-SSA seropositivity, suggesting a role for lipid metabolism in CLE subtype differentiation and disease severity [41,42]. This evidence concerns the gene CALR and systemic lupus erythematosus.